Cilostazol protects endothelial cells against lipopolysaccharide-induced apoptosis through ERK1/2- and P38 MAPK-dependent pathways.
about
Ginkgo biloba extract (GbE) enhances the anti-atherogenic effect of cilostazol by inhibiting ROS generation.Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells.Cilostazol Improves Proangiogenesis Functions in Human Early Endothelial Progenitor Cells through the Stromal Cell-Derived Factor System and Hybrid Therapy Provides a Synergistic Effect In Vivo.Protective effects of cilostazol on ethanol-induced damage in primary cultured hepatocytes.
P2860
Cilostazol protects endothelial cells against lipopolysaccharide-induced apoptosis through ERK1/2- and P38 MAPK-dependent pathways.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cilostazol protects endothelia ...... d P38 MAPK-dependent pathways.
@en
Cilostazol protects endothelia ...... d P38 MAPK-dependent pathways.
@nl
type
label
Cilostazol protects endothelia ...... d P38 MAPK-dependent pathways.
@en
Cilostazol protects endothelia ...... d P38 MAPK-dependent pathways.
@nl
prefLabel
Cilostazol protects endothelia ...... d P38 MAPK-dependent pathways.
@en
Cilostazol protects endothelia ...... d P38 MAPK-dependent pathways.
@nl
P2093
P2860
P1476
Cilostazol protects endothelia ...... d P38 MAPK-dependent pathways.
@en
P2093
Jae-Suk Woo
Jong-Hoon Lim
Yung-Woo Shin
P2860
P304
P356
10.3904/KJIM.2009.24.2.113
P577
2009-06-08T00:00:00Z